Advertisement
Screener

CANDEL THERAPEUTICS, INC. (CADL) Material Contracts

CANDEL THERAPEUTICS, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-13: Form 10-Q; Exhibit 10.4; Description Amended and Restated Non-Employee Director Compensation Policy, effective as of June 12, 2026..
  • 2026-08-13: Form 10-Q; Exhibit 10.2; Description Employment Agreement, effective as of July 6, 2026, by and between Candel Therapeutics, Inc. and Mark Sims.
  • 2026-06-16: Form 8-K; Exhibit 10.1; Description Employment Agreement, effective as of June 12, 2026, by and between Candel Therapeutics, Inc. and Charles Schoch.
  • 2026-05-14: Form 10-Q; Exhibit 10.1; Description First Amendment to Master Production Services Agreement by and between Candel Therapeutics and SAFC Carlsbad, Inc. dated April 9, 2026..
FiledFormExhibitDescription
2026-08-1310-Q10.4Amended and Restated Non-Employee Director Compensation Policy, effective as of June 12, 2026.
2026-08-1310-Q10.2Employment Agreement, effective as of July 6, 2026, by and between Candel Therapeutics, Inc. and Mark Sims
2026-06-168-K10.1Employment Agreement, effective as of June 12, 2026, by and between Candel Therapeutics, Inc. and Charles Schoch
2026-05-1410-Q10.1First Amendment to Master Production Services Agreement by and between Candel Therapeutics and SAFC Carlsbad, Inc. dated April 9, 2026.
2026-03-1210-K10.22First Amendment to Loan and Security Agreement, by and among the Registrant, Trinity Capital Inc., and the other parties thereto, dated as of March 10, 2026.
2026-03-1210-K10.21Purchase Agreement by and between Candel Therapeutics, Inc. and RTW Investments, LP, dated as of February 19, 2026
2026-03-1210-K10.20Candel Therapeutics, Inc. Non-Employee Director Compensation Policy
2026-03-1210-K10.19Candel Therapeutics, Inc. 2025 Inducement Plan and forms of award agreements thereunder
2025-10-148-K10.2Form of Omnibus Amendment, Release and Waiver to Warrants to Purchase Common Stock, by and among the Registrant and the other parties thereto, dated as of October 14, 2025.
2025-10-148-K10.1Loan and Security Agreement, by and among the Registrant, Trinity Capital Inc. and the other parties thereto, dated as of October 14, 2025.
2025-08-218-K10.1First Amendment to Lease of Premises at 117 Kendrick Street, Needham, Massachusetts by and between 117 Kendrick DE, LLC and the Registrant dated as of August 18, 2025.
2025-06-248-K10.1Securities Purchase Agreement, dated June 23, 2025, by and among Candel Therapeutics, Inc. and the parties named therein.
2024-03-2810-K10.19Consulting by and between Candel Therapeutics, Inc. and Jason A. Amello, dated as of January 12, 2024
2023-08-1010-Q10.2First Amendment to Loan and Security Agreement by and between Candel Therapeutics, Inc. and Silicon Valley Bank, dated June 14, 2023
2023-08-1010-Q10.1Amendment to Exclusive License Agreement by and between Candel Therapeutics, Inc. and Periphagen, Inc., dated June 7, 2023
2023-03-3010-K10.16Master Production Services Agreement by and between Candel Therapeutics and SAFC Carlsbad, Inc., effective November 3, 2022
2022-11-1010-Q10.1Employment Agreement by and between Candel Therapeutics and Jason A. Amello dated September 21, 2022
2022-08-0510-Q10.1Employment Agreement by and between Candel Therapeutics and Seshu Tyagarajan dated April 14, 2022
2022-05-1210-Q10.8Employment Agreement by and between Candel Therapeutics and Seshu Tyagarajan dated April 14, 2022
2022-03-2910-K10.13Consulting Agreement by and between Candel Therapeutics, Inc. and Susan Stewart dated October 19, 2021.
2022-03-2910-K10.12Employment Agreement by and between Candel Therapeutics and Francesca Barone dated February 3, 2022
2022-03-2910-K10.11Loan and Security Agreement by and between the Registrant and Silicon Valley Bank, dated February 24, 2022

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61